中
Home
About TUL
Group Introduction
Executive Directors
Subsidiaries
Contact Us
Innovation in R&D
R&D Pipeline
R&D Platform
R&D Updates
News
TUL Highlights
Product Center
Finished Products
Comprehensive Health Products
APIs and Intermediates
Animal protection products
Empty capsule
Medical device
Cosmetic Peptide Series
Sustainability
Enhancing Governance
Normalizing Healthiness
Brand Building
People-Oriented
Green Development
ESG Reports
ESG News
Investor Relations
News
TUL Highlights
the first non-sterile raw material drug production line of Zhuhai United Laboratories Animal Healthcare Co., Ltd. successfully passed the on-site inspection and acceptance of the new version of the veterinary drug GMP
Date：2025-07-09
Views：583
Previous：
The global launch conference and the completion and commissioning ceremony of the cephalosporin product base of TUL were grandly held
Next：
TUL has won the China Patent Excellence Award
WeChat
Official
Account
To Top
粤公网安备44040402000348号